Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06379360 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Maintenance Therapy of Hypomethylating Agent (HMA) in Favorable Risk Acute Myeloid Leukemia (AML) Patients

StatusActive, Not Recruiting
PhasePhase 2
Started
View on ClinicalTrials.gov ↗
Trial flagged as At Risk
Enrollment reduced 22% 77 → 60 participants
See other at-risk trials from The First Affiliated Hospital of Soochow University

Record History

See every version on ClinicalTrials.gov ↗

  1. Enrollment closed, study ongoing Show 6 more changesShow less
    • Enrollment reduced: 77 → 60 participants
    • Primary completion date changed from estimate of Dec 1, 2026 to Jul 31, 2026
    • Start date: Nov 1, 2020 to Jul 1, 2019
    • Eligibility criteria expanded, about 12 words
    • Site details revised
    • Collaborators expanded, about 16 words
  2. Primary completion date: Dec 1, 2025 to Dec 1, 2026v5
  3. Primary completion date: Dec 1, 2024 to Dec 1, 2025v4
  4. Primary completion date: May 1, 2024 to Dec 1, 2024v3
  5. Eligibility criteria expanded, about 23 words
    • Study title expanded, about 5 words
    v2
  6. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
HMA maintenance therapy is expected to benefit overall survival (OS) and relapse free survival (RFS) in AML patients with favorable risk.
Trial Details
NCT Number NCT06379360
Lead Sponsor The First Affiliated Hospital of Soochow University
Collaborators: Canglang Hospital of Suzhou, The Second People's Hospital of Huai'an, Suzhou Hospital of Traditional Chinese Medicine
Conditions
(from sponsor)		 Acute Myeloid Leukemia
Related terms Leukemia, Myeloid, Acute
Enrollment 60 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov